JPMorgan Maintains Illumina at Overweight, Cuts Target to $300
JPMorgan maintained its Overweight rating on Illumina and lowered its price target to $300 from $320.
Story updates
12:06:20 AM UTC
SquawkNews
Illumina Price Target Cut to $300.00/Share From $320.00 by JP Morgan